References
- Ball, A. & Winstead, P. (2008). Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. Pharmacotherapy, 28, 1383–1390.
- Bavister, B., Kinsey, D., Lane, M., & Gardner, D. (2003). Recombinant human albumin supports hamster in-vitro fertilization. Human Reproduction, 18, 113–116.
- Bhullar, I., Braman, R., & Block, E. (2007). Recombinant factor VII as an adjunct to control of hemorrhage from chest trauma in a Jehovah's Witness. The American Surgeon, 73, 818–819.
- Dutney, A. (2007). Religion, infertility and assisted reproductive technology. Best Practice & Research Clinical Obstetrics and Gynecology, 21, 169–180.
- Elder, L. (2000). Why some Jehovah's Witnesses accept blood and conscientiously reject official Watchtower Society blood policy. Journal of Medical Ethics, 26, 375–380.
- Gerris, J. (1999). Methods of semen collection not based on masturbation or surgical sperm retrieval. Human Reproduction Update, 5, 211–215.
- Healy, D. & Evans, J. (1993). Creutzfeldt-Jakob disease after pituitary gonadotrophins. British Medical Journal, 307, 517–518.
- Holmes, H. (1989). Hepatitis – yet another risk of in vitro fertilization? Reproductive and Genetic Engineering, 2, 29–37.
- Huirne, J. & Schats, R. (2009). The use of GnRH agonists. In: Gardner, D., Weissman, A., Howles, C., Shoham, Z., (Eds), Textbook of assisted reproductive technologies: laboratory and clinical perspectives. London: Informa UK Ltd.; p 529–538.
- Katz-Jaffe, M., Schoolcraft, W., & Gardner, D. (2006). Analysis of protein expression (secretome) by human and mouse preimplantation embryos. Fertility and Sterility, 86, 678–685.
- Knuti, K., Amrein, P., Chabner, B., Lynch Jr, T.J., & Penson, R. (2002). Faith, identity, and leukemia: when blood products are not an option. Oncologist, 7, 371–380.
- Muramoto, O. (1999). Recent developments in medical care of Jehovah's Witnesses. The Western Journal of Medicine, 170, 297–301.
- Muramoto, O. (2000). Medical confidentiality and the protection of Jehovah's Witnesses' autonomous refusal of blood. Journal of Medical Ethics, 26, 381–386.
- Nagy, Z., Chang, C., Shapiro, D., Bernal, D., Elsner, C., Mitchell-Leef, D., Toledo, A., & Kort, H. (2009). Clinical evaluation of the efficiency of an oocyte donation program using cryo-banking. Fertility and Sterility, 92, 520–526.
- Penton, J. (1997). Apocalypse delayed: the story of Jehovah's Witnesses, 2nd ed. Toronto: University of Toronto Press Inc.
- Reichl, H., Balen, A., & Jansen, C. (2002). Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins? Human Reproduction, 17, 2501–2508.
- Ridley, D. (1999). Jehovah's Witnesses' refusal of blood: obedience to scripture and religious conscience. Journal of Medical Ethics, 25, 469–472.
- Robertson, J. (2004a). Reproductive technology in Germany and the United States: an essay in comparative law and bioethics. Columbia Journal of Transnational Law, 43, 189–227.
- Robertson, J. (2004b). Protecting embryos and burdening women: assisted reproduction in Italy. Human Reproduction, 19, 1693–1696.
- Rogers, D. & Crookston, K. (2006). The approach to the patient who refuses blood transfusion. Transfusion (Paris), 46, 1471–1477.
- Tyler, J. (1983). How representative are semen samples? Lancet, 321, 191.
- van Wolfswinkel, M., Zwart, J., Schutte, J., Duvekot, J., Pel, M., & van Roosmalen, J. (2009). Maternal mortality and serious maternal morbidity in Jehovah's Witnesses in the Netherlands. British Journal of Obstetrics and Gynaecology, 116, 1103–1110.
- Varela, J., Gomez-Marin, O., Fleming, L., & Cohn, S. (2003). The risk of death for Jehovah's Witnesses after major trauma. Journal of Trauma, 54, 967–972.
- Wilson, L., Breen, T., Keeping, G., Hennessey, J., & Harrison, K. (1990). Successful use of follicular fluid as a serum substitute in in vitro fertilization culture medium for a Jehovah's Witness. Infertility, 13, 73–76.
- Zobeley, E., Flechsig, E., Cozzio, A., Enari, M., & Weissmann, C. (1999). Infectivity of scrapie prions bound to a stainless steel surface. Molecular Medicine, 5, 240–243.